CSIMarket
 
Regeneron Pharmaceuticals Inc   (NASDAQ: REGN)
 

Regeneron Pharmaceuticals Inc's Suppliers Performance

REGN's Supply Chain




 
REGN Costs vs Sales of Suppliers Growth Regeneron Pharmaceuticals Inc recorded an increase in cost of sales by 109.18 % year on year, sequentially cost of sales grew by 54.39 % in Q2.

• More on REGN Suppliers



Regeneron Pharmaceuticals Inc recorded increase in cost of sales by 109.18 % year on year, sequentially cost of sales grew by 54.39 % in Q2.

• More on REGN Suppliers




Regeneron Pharmaceuticals Inc's Comment on Supply Chain









REGN's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Regeneron Pharmaceuticals Inc 83,833.28 15,534.70 4,328.70 15,410
SUBTOTAL 0.00 0.00 0.00 -


Sources: Regeneron Pharmaceuticals Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Regeneron Pharmaceuticals Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.